Literature DB >> 19135685

Sporadic primary hyperparathyroidism in young individuals: different disease and treatment?

Mark S Sneider1, Carmen C Solorzano, Raquel E Montano, Charles Anello, George L Irvin, John I Lew.   

Abstract

BACKGROUND: Younger individuals with hyperparathyroidism may experience severe disease with a higher incidence of multigland disease (MGD) and operative failure, thereby requiring subtotal parathyroidectomy. This study examines the characteristics and surgical outcome of younger compared with older patients with sporadic primary hyperparathyroidism (SPHPT).
METHODS: Prospectively collected data of 1101 patients with SPHPT who underwent parathyroidectomy at a single institution were retrospectively reviewed. Patients with multiple endocrine neoplasia (MEN), familial, secondary, or tertiary hyperparathyroidism, parathyroid carcinoma, rickets, or lithium induced disease were excluded. Patients were subdivided into two groups: (1) younger individuals < or = 40 y of age (n = 110) and (2) older individuals > 40 y of age (n = 991). Both age groups were compared for gender, clinical manifestations, pre- and postoperative laboratory values, MGD, operative success, and recurrent disease.
RESULTS: There was greater male predominance in younger compared with older patients treated for SPHPT (41% versus 25%, P = 0.0004). Of the clinical manifestations of SPHPT, kidney stones were more common in younger compared with older individuals (45% versus 29%, P = 0.0006). Conversely, bone pain was more common in older compared with younger patients (32% versus 14%, P = 0.0002). There was no statistical difference in biochemical values, MGD, and outcome between both groups.
CONCLUSIONS: Despite male predominance and few differences in symptoms, SPHPT is a similar disease entity in both younger and older individuals. Patients from both age groups can be similarly treated for SPHPT with a high rate of operative success. Routine BNE and subtotal parathyroidectomy is not necessary in younger individuals.

Entities:  

Mesh:

Year:  2008        PMID: 19135685     DOI: 10.1016/j.jss.2008.07.041

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

1.  The changing pattern of diagnosing primary hyperparathyroidism in young patients.

Authors:  Irene Lou; David F Schneider; Rebecca S Sippel; Herbert Chen; Dawn M Elfenbein
Journal:  Am J Surg       Date:  2016-06-14       Impact factor: 2.565

Review 2.  Surgical approaches in hereditary endocrine tumors.

Authors:  Maurizio Iacobone; Marilisa Citton; Giovanni Viel; Donatella Schiavone; Francesca Torresan
Journal:  Updates Surg       Date:  2017-04-28

3.  CT-MIBI-SPECT image fusion predicts multiglandular disease in hyperparathyroidism.

Authors:  Gerd Wimmer; Christoph Profanter; Peter Kovacs; Michael Sieb; Michael Gabriel; Daniel Putzer; Reto Bale; Raimund Margreiter; Rupert Prommegger
Journal:  Langenbecks Arch Surg       Date:  2009-08-25       Impact factor: 3.445

4.  Single Gland, Ectopic Location: Adenomas are Common Causes of Primary Hyperparathyroidism in Children and Adolescents.

Authors:  Robert D Rampp; Edna E Mancilla; N Scott Adzick; Michael A Levine; Rachel R Kelz; Douglas L Fraker; Pallavi Iyer; Brenessa M Lindeman; Vicente A Mejia; Herbert Chen; Heather Wachtel
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

5.  Primary hyperparathyroidism in adolescents: the same but different.

Authors:  Itai Pashtan; Raymon H Grogan; Sharone P Kaplan; Karen Devon; Peter Angelos; Donald Liu; Edwin L Kaplan
Journal:  Pediatr Surg Int       Date:  2012-11-25       Impact factor: 1.827

6.  Do giant parathyroid adenomas represent a distinct clinical entity?

Authors:  Philip M Spanheimer; Andrew J Stoltze; James R Howe; Sonia L Sugg; Geeta Lal; Ronald J Weigel
Journal:  Surgery       Date:  2013-08-23       Impact factor: 3.982

7.  PRIMARY HYPERPARATHYROIDISM - STRATEGY FOR MULTIGLAND DISEASE IN THE ERA OF SPECT-CT.

Authors:  I T Cvasciuc; W Ismail; M Lansdown
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jan-Mar       Impact factor: 0.877

8.  Primary hyperparathyroidism masquerading as rickets: diagnostic challenge and treatment outcomes.

Authors:  Deep Dutta; Manoj Kumar; Ram Narayan Das; Saumik Datta; Dibakar Biswas; Sujoy Ghosh; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.